临床药物治疗杂志2024,Vol.22Issue(7) :87-89.DOI:10.3969/j.issn.1672-3384.2024.07.016

吸入用布地奈德混悬液致腹腔感染患者白细胞升高一例

A case of leukocytosis induced by budesonide suspension for inhalation in a patient with abdominal infection

王哲 褚燕琦 贺少龙 马艺溢
临床药物治疗杂志2024,Vol.22Issue(7) :87-89.DOI:10.3969/j.issn.1672-3384.2024.07.016

吸入用布地奈德混悬液致腹腔感染患者白细胞升高一例

A case of leukocytosis induced by budesonide suspension for inhalation in a patient with abdominal infection

王哲 1褚燕琦 2贺少龙 3马艺溢4
扫码查看

作者信息

  • 1. 首都医科大学宣武医院 药学部,北京 100053;内蒙古自治区鄂尔多斯市中心医院 药剂科 内蒙古 鄂尔多斯 017000
  • 2. 首都医科大学宣武医院 药学部,北京 100053
  • 3. 宁夏医科大学总医院 药剂科,银川 750000
  • 4. 暨南大学附属第一医院(广州市华侨医院)药学部,广州 510630
  • 折叠

摘要

讨论1例腹腔感染患者术后使用吸入用布地奈德混悬液致白细胞升高的罕见不良反应识别及药学监护.临床药师分析腹腔感染患者用药经过,得出患者白细胞升高可能与吸入用布地奈德混悬液相关,通过停药、优化治疗方案并对患者实施药学监护,患者白细胞水平快速恢复,保障了患者用药安全.

Abstract

To discuss the identification and pharmaceutical care of a rare adverse reaction of leukocytosis caused by the use of inhaled budesonide suspension in a patient with abdominal infection.The clinical pharmacist analyzed the medication process of the patient with abdominal infection and concluded that the patient's elevated white blood cell count may be related to the use of budesonide suspension for inhalation.By discontinuing the medication,optimizing the treatment plan,and implementing pharmaceutical care for the patient,the patient's white blood cell counts rapidly returned to normal,ensuring the safety of the patient's medication.

关键词

临床药师/吸入用布地奈德混悬液/白细胞升高/药品不良反应

Key words

clinical pharmacist/inhaled budesonide suspension for inhalation/leukocytosis/adverse drug reactions

引用本文复制引用

出版年

2024
临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
参考文献量11
段落导航相关论文